Skip to main content

Table 2 Coagulation tests, detailed

From: The use of eculizumab in Capnocytophaga canimorsus associated thrombotic microangiopathy: a case report

Coagulation tests (Oslo) Time after adm. to univ.hospital
  Unit [ref] 0 h 8 h 16 h
Hemoglobin g/dL [11.7-15.3] 10.6 9.8 8.2
Haptoglobin g/L [0.4-2.1] 0.1 0.1 0.5
Thrombocyte count 10E9/L [145-390] 20 16 10
INR N-ratio [0.8-1-2] 1.2 1.1 1
D-dimer [< 0.5] > 4 (in local hospital)  
Thrombin time sec [30-42] 21 >120  
Fibrinogen g/L [2.0-4.0] 2.6 3 3.3
APTT sec [30-42]   169 48
APTT (phospholipid antibody independent) sec [25-37] 49   
Antithrombin activity /FIIa-based reactant) IU/dL [80-120] 46 45 69
Prothrombin time sec [9.4-12.5] 10.7   
  1. APTT Activated prothrombin time, INR International normalized ratio
\